These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12637322)

  • 1. Human NK cell development in NOD/SCID mice receiving grafts of cord blood CD34+ cells.
    Kalberer CP; Siegler U; Wodnar-Filipowicz A
    Blood; 2003 Jul; 102(1):127-35. PubMed ID: 12637322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
    Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
    Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective expansion and engraftment of human CD16+ NK cells in NOD/SCID mice.
    Harada H; Suzu S; Ito T; Okada S
    Eur J Immunol; 2005 Dec; 35(12):3599-609. PubMed ID: 16304638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intra-bone marrow infusion of human cord blood hematopoietic stem/progenitor cells improves hematopoietic reconstitution in NOD-SCID mice].
    Meng ZT; Gao JT; Lu SH; Yan X; Li YH; Yang Z; Zheng YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1010-5. PubMed ID: 19698249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.
    Ito M; Hiramatsu H; Kobayashi K; Suzue K; Kawahata M; Hioki K; Ueyama Y; Koyanagi Y; Sugamura K; Tsuji K; Heike T; Nakahata T
    Blood; 2002 Nov; 100(9):3175-82. PubMed ID: 12384415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells.
    Mrózek E; Anderson P; Caligiuri MA
    Blood; 1996 Apr; 87(7):2632-40. PubMed ID: 8639878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/gammacnull mice model.
    Hiramatsu H; Nishikomori R; Heike T; Ito M; Kobayashi K; Katamura K; Nakahata T
    Blood; 2003 Aug; 102(3):873-80. PubMed ID: 12689924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
    Yoshino H; Ueda T; Kawahata M; Kobayashi K; Ebihara Y; Manabe A; Tanaka R; Ito M; Asano S; Nakahata T; Tsuji K
    Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells.
    André MC; Erbacher A; Gille C; Schmauke V; Goecke B; Hohberger A; Mang P; Wilhelm A; Mueller I; Herr W; Lang P; Handgretinger R; Hartwig UF
    J Immunol; 2010 Sep; 185(5):2710-20. PubMed ID: 20668220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions.
    Carayol G; Robin C; Bourhis JH; Bennaceur-Griscelli A; Chouaib S; Coulombel L; Caignard A
    Eur J Immunol; 1998 Jun; 28(6):1991-2002. PubMed ID: 9645381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel subpopulation of human cord blood CD34-CD133-CD7-CD45+lineage- cells capable of lymphoid/NK cell differentiation after in vitro exposure to IL-15.
    Rutella S; Bonanno G; Marone M; De Ritis D; Mariotti A; Voso MT; Scambia G; Mancuso S; Leone G; Pierelli L
    J Immunol; 2003 Sep; 171(6):2977-88. PubMed ID: 12960322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-mouse CD122 antibody promotes the hematopoietic repopulating capacity of cord blood CD34⁺ cells in NOD/SCID mice].
    Sheng MY; Shi H; Xing W; Wang WJ; Si XH; Bai J; Yuan WP; Zhou Y; Yang FC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1673-7. PubMed ID: 25543495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice.
    Siegler U; Kalberer CP; Nowbakht P; Sendelov S; Meyer-Monard S; Wodnar-Filipowicz A
    Leukemia; 2005 Dec; 19(12):2215-22. PubMed ID: 16224486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahepatic transplantation of CD34+ cord blood stem cells into newborn and adult NOD/SCID mice induce differential organ engraftment.
    Wulf-Goldenberg A; Keil M; Fichtner I; Eckert K
    Tissue Cell; 2012 Apr; 44(2):80-6. PubMed ID: 22197619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15.
    Yu H; Fehniger TA; Fuchshuber P; Thiel KS; Vivier E; Carson WE; Caligiuri MA
    Blood; 1998 Nov; 92(10):3647-57. PubMed ID: 9808558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence.
    Strowig T; Chijioke O; Carrega P; Arrey F; Meixlsperger S; Rämer PC; Ferlazzo G; Münz C
    Blood; 2010 Nov; 116(20):4158-67. PubMed ID: 20671122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of human short-term repopulating cell (STRC) engraftment in NOD/SCID mice by host CD122+ cells.
    Shultz LD; Banuelos SJ; Leif J; Appel MC; Cunningham M; Ballen K; Burzenski L; Greiner DL
    Exp Hematol; 2003 Jun; 31(6):551-8. PubMed ID: 12829032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice.
    Lam AC; Li K; Zhang XB; Li CK; Fok TF; Chang AM; James AE; Tsang KS; Yuen PM
    Transfusion; 2001 Dec; 41(12):1567-76. PubMed ID: 11778074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Post-transplant cell immune reconstitution in humanized NOD/SCID mice].
    Yang H; Hu W; Jia X; Deng F
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):533-6. PubMed ID: 24796750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The cytotoxicity of CIK/NK cells stimulated by K562-DC fusion vaccines in NOD/SCID mice model for human erythroleukemia].
    Li Y; Huang SL; Zhang XC; Fang JP; Wu YF; Wei J; Huang WG; Zhou DH; Huang K; Lin YC
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):39-43. PubMed ID: 18512314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.